← Back to Search

Other

Augmented Reality Assistance for Phlebotomy

N/A
Waitlist Available
Led By Ali H Dhanaliwala, MD, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at end of procedure, on average 30 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trial uses special glasses that show ultrasound images to help doctors place IV catheters more accurately in patients who need precise IV access.

Who is the study for?
This trial is for adults (18+) who need help placing an IV with ultrasound guidance. It's not suitable for those needing urgent or emergency IV placement.
What is being tested?
The study tests if using an augmented reality headset to see ultrasound images helps in guiding the insertion of an intravenous catheter more effectively.
What are the potential side effects?
Since this trial involves a non-invasive technology, there may be minimal side effects related to discomfort from wearing the headset or distraction during the procedure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at end of procedure, on average 30 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and at end of procedure, on average 30 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Cannulation rate
Secondary study objectives
Cannulation attempts

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Augmented RealityExperimental Treatment1 Intervention
Subjects in this group will have their intravenous catheter placed while the physician uses a mixed reality headset to view the ultrasound images being used to guide the catheter placement.
Group II: ControlActive Control1 Intervention
Subjects in this group will have their intravenous catheter placed using standard of care. The physician will use the monitor on the ultrasound machine only to view the ultrasound images being used to guide the catheter placement.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Phlebotomy, commonly used to treat conditions like polycythemia vera, involves the removal of blood to decrease red blood cell mass and reduce blood viscosity. This helps prevent complications such as thrombosis. The use of augmented reality headsets for enhanced visualization of ultrasound images can significantly improve the accuracy and efficiency of intravenous catheter placement during phlebotomy. This technology allows healthcare providers to better visualize veins, reducing the risk of complications and improving patient outcomes.
Effectiveness of caregiver-mediated exercise interventions on activities of daily living, anxiety and depression post-stroke rehabilitation: A systematic review and meta-analysis.Phlebotonics for venous insufficiency.Lessons Learned From a Randomized Controlled Trial of Short-Course Intravenous Antibiotic Therapy for Erysipelas and Cellulitis of the Lower Limb (Switch Trial).

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,082 Previous Clinical Trials
42,727,330 Total Patients Enrolled
Ali H Dhanaliwala, MD, PhDPrincipal InvestigatorUniversity of Pennsylvania
1 Previous Clinical Trials
20 Total Patients Enrolled

Media Library

Augmented Reality Heads-up Display (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05710445 — N/A
Phlebotomy Clinical Trial 2023: Augmented Reality Heads-up Display Highlights & Side Effects. Trial Name: NCT05710445 — N/A
Augmented Reality Heads-up Display (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05710445 — N/A
Phlebotomy Research Study Groups: Control, Augmented Reality
~0 spots leftby Dec 2025